If your institution subscribes to this resource, and you don't have an Access Profile, please contact your library's reference desk for information on how to gain access to this resource from off-campus.
Take the Access library with you wherever you go—easy access to books, videos, images, podcasts, personalized features, and more.
Download the Access App here: iOS and Android. Learn more here!
Hyrimoz16,138,*
Tumor necrosis factor alpha–directed monoclonal antibody
Biosimilar [not interchangeable] for adalimumab (Humira);139 adalimumab-adbm* adalimumab-atto
Ankylosing spondylitis; Crohn’s disease; juvenile idiopathic arthritis; plaque psoriasis; psoriatic arthritis; rheumatoid arthritis; ulcerative colitis
Chapter 3. Pharmacodynamics: Molecular Mechanisms of Drug Action > TNF-α Receptors
eChapter 2018 Part 2: The Goodman & Gilman Year in Review: 2018 New and Noteworthy FDA Approvals